Few Older Women Are Aware of Guidelines on When to Stop Breast Cancer Screening
The authors have nothing to report. No author had any conflicts of interest. Dr. Pollack has stock ownership in Gilead Sciences Inc. Dr. Boyd receives honorarium from UpToDate for authoring a chapter on multimorbidity. However, we do not believe these have resulted in any conflict with the design, methodology, or results presented in this manuscript. Table S1: Summary of US clinical guidelines on when to stop breast cancer screening in average risk women. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Authors
- Qian‐Li Xue (ORCID: https://orcid.org/0000-0001-8818-7444)
- Craig Evan Pollack (ORCID: https://orcid.org/0000-0003-2464-6415)
- Cynthia M. Boyd (ORCID: https://orcid.org/0000-0001-5642-9015)
- Rebekah H. Nagler (ORCID: https://orcid.org/0000-0003-1479-4115)
- Mara A. Schonberg (ORCID: https://orcid.org/0000-0001-5162-5922)
- Sarah E. Gollust (ORCID: https://orcid.org/0000-0001-6109-5953)
- Nancy L. Schoenborn (ORCID: https://orcid.org/0000-0001-5053-5132)
Institutions
- University of Minnesota (US)
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Minnesota Department of Health (US)
Publication Details
- Journal
- Journal of the American Geriatrics Society
- Published
- 2025-09-04
- DOI
- https://doi.org/10.1111/jgs.70080
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute on Aging